Royal Bank Of Canada Replimune Group, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Replimune Group, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 7,983 shares of REPL stock, worth $91,804. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,983
Previous 8,540
6.52%
Holding current value
$91,804
Previous $93,000
3.23%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding REPL
# of Institutions
161Shares Held
74.9MCall Options Held
38.4KPut Options Held
43.7K-
Baker Bros. Advisors LP New York, NY11MShares$127 Million1.48% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$126 Million0.02% of portfolio
-
Redmile Group, LLC San Francisco, CA4.91MShares$56.4 Million4.65% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$54.2 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.97MShares$45.7 Million8.12% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $567M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...